Clinically known as glucagon-like peptide 1 agonists , GLP-1s were originally developed to treat diabetes
In 2026 theres also a third path: new oral GLP-1 pills
Modern eating habits have changed the way we respond to hunger
Public trial doses can help you understand research, but they should not guide self-treatment
The information garnered through this new study provides important insights to develop more effective and personalized weight management interventions to reduce a postmenopausal womans risk of overweight and obesity-related health complications, added Maria Daniela Hurtado Andrade, M.D., Ph.D., assistant professor of medicine and consultant for the Division of Endocrinology at the Mayo Clinic.
But there are less commonalbeit, more seriousside effects that could occur, including gallbladder attacks and pancreatitis (i.e., inflammation of the pancreas), says Dr